Cas9 fusion protein and its coding sequence

A technology of fusion protein and coding sequence, which is applied in the field of DNA sequence, can solve the problems affecting gene targeting efficiency and chimeric effect, and achieve the effects of reducing gene targeting chimeric effect, improving the accuracy of gene modification, and reducing the effect of chimeric mutation

Active Publication Date: 2017-08-18
广州元曦生物科技有限公司 +1
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, the cell's own DNA damage repair mechanism or DNA non-homologous recombination repair will also affect gene targeting efficiency and chimerism

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cas9 fusion protein and its coding sequence
  • Cas9 fusion protein and its coding sequence
  • Cas9 fusion protein and its coding sequence

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Construct the expression vector of the target plasmid Ub-i-Cas9 (i represents R, L, P) containing different protein degradation signals, the schematic diagram is as follows figure 1 , the construction process method is as follows ( figure 2 ).

[0042] For ease of construction, first use the NotI and EcoRI restriction sites on the MLM3613Cas9 (Addgene, Plasmid#42251, called WT-Cas9) backbone plasmid to contain the T7 promoter, NcoI cloning restriction site, and translation initiation site. Points and fragments of part of the Cas9 protein sequence were cut and ligated on the pGEX4T-1 plasmid ( figure 2 a, b), pGEX4T1-NotI-T7-NcoI-Cas9-EcoRI-. Subsequently, design upstream primers with NotI restriction site and T7 promoter sequence I and downstream primers with Myc-tag sequence, L / P / L site and NocI restriction site (sequences are respectively as SEQ ID NO .22, shown in SEQ ID NO.23-25), introduce the DNA sequence of L / P / R amino acid simultaneously in the downstream p...

Embodiment 2

[0056] Construction of CRISPR / Cas9 sgRNA vectors containing PINK1, Parkin and ASPM gene target sequences.

[0057] Table 1. Target Sequence Sites

[0058]

[0059] Note: The sequence underlined is the PAM sequence of the sgRNA, that is, its binding site with the target DNA sequence.

[0060] The sgRNA target sequence vector constructed above and the Cas9 plasmid vectors before and after transformation were linearized with PmeI enzyme, recovered from the gel, and synthesized by in vitro transcription.

[0061]The sgRNA expression vector contains a T7 promoter to control the expression of sgRNA, and can insert a 20bp sgRNA specific target sequence after digestion with BbsI restriction enzyme, and the recognition site of the specific target sequence is located in the second exon of PINK1 gene , the second exon of the Parkin gene, the third exon and the tenth exon of the ASPM gene. In order to screen the sgRNA sequences of PINK1 and ASPM genes capable of gene editing and with...

Embodiment 3

[0063] The half-life detection of the constructed Ub-i-Cas9 (i stands for LP, R) plasmid.

[0064] First, WT-Cas9 and Ub-i-Cas9 plasmids were transfected into 293 cells. After 48 hours of transfection, the results of Western blot detection of Cas9 protein expression showed that, based on WT-Cas9 as 100%, Ub-L-Cas9, Ub-L-Cas9, Ub-P-Cas9 and Ub-R-Cas9 were degraded to 84.76%, 80.92% and 63.89%, respectively.

[0065] Especially for Ub-R-Cas9, although there is only one base difference between Ub-L-Cas9 and Ub-P-Cas9 in its sequence, it is surprisingly found that its degradation rate is significantly faster than other fusion proteins, reached a very rare level.

[0066] Subsequently, we compared the half-life of WT-Cas9 and Ub-R-Cas9, that is, after 24 hours of plasmid transfection, 50 micromolar cycloheximide was added to the medium, respectively at 0h, 2h, 4h, 8h, 12h , 24h to collect cells, Western blot detection results are as follows image 3 As shown in B and C, compared...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biology, and relates to fusion protein and the DNA sequence for coding the fusion protein, in particular to the Cas9 fusion protein with a Cas9 segment and a Ubiquitin segment, and the coding sequence of the Cas9 fusion protein. On one hand, the Cas9 protein can be rapidly degraded after playing a targeting role in an embryonic cell, and therefore the chimerism mutation effect on embryonic development is reduced. More importantly, by means of the Ubiquitin-i-cas9 protein, the homozygosis efficiency of a gene targeting embryo can be improved, wherein i is the first-place amino acid of a connector for connecting Ubiquitin and Cas9 and can be arginine (R) or proline (P) or leucine (L). Especially, the targeting efficiency of the particularly-preferential Ubiquitin-R-Cas9 protein for a wild type Cas9 protein gene is improved by 3.51 times and is beyond the expectation of technicians.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a fusion protein and a DNA sequence encoding the fusion protein. [0002] technical background [0003] Animal disease models play a key role in the study of human disease pathogenesis and drug screening. Non-human primates are highly similar to humans in biology and genetics, for example, macaques share 93% of their genomes with humans (Gibbs et al., 2007), and thus become an important animal model for major human disease research and drug screening . However, due to the lack of large animal embryonic stem cell lines, traditional gene targeting technology is difficult to use to establish primate disease models. The gene editing technology CRISPR / Cas9 developed in recent years has shown great potential in targeted and precise modification of genes, and has been widely used in genome modification and gene modification in different species. At the same time, this new technology has als...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N9/22C07K19/00C12N15/62C12N15/85
CPCC07K2319/95C12N9/22C12N15/85C12N2800/107C12N2810/10
Inventor 李晓江涂著池杨伟莉郭祥玉李世华
Owner 广州元曦生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products